Literature DB >> 11478413

Monocyte chemoattractant protein-1 and interleukin-8 are increased in bronchopulmonary dysplasia: relation to isolation of Ureaplasma urealyticum.

R J Baier1, J Loggins, T E Kruger.   

Abstract

BACKGROUND: An exaggerated inflammatory response occurs in infants who subsequently develop bronchopulmonary dysplasia (BPD). Ureaplasma urealyticum (Uu) is frequently isolated from cultures of tracheal secretions obtained from very low birth weight infants and is associated with an increased risk of BPD.
METHODS: We examined the relationships between isolation of genital mycoplasmas, tracheal aspirate (TA) interleukin-8 (IL-8), and monocyte chemoattractant protein-1 (MCP-1) concentrations and the development of BPD. Serial TAs were obtained prospectively from 35 very low birth weight infants, and IL-8 and MCP-1 concentrations were determined by enzyme-linked immunoadsorbent assay. Tracheal cultures for bacteria and genital mycoplasmas were performed on aspirates obtained during the first 2 days of life.
RESULTS: Infants who developed BPD (n=18) were less mature (25.2+/-0.2 vs 27.8+/-0.5 weeks; P<0.001), of lower birth weight (746+/-28 vs 1052+/-41 g; P<0.001), and more likely to have a positive tracheal culture for Uu (39% vs 6%; P=0.026) than those who did not develop BPD (n=17). Tracheal concentrations of IL-8 and MCP-1 were significantly increased in infants who developed BPD (IL-8: P=0.0001; MCP-1: P<0.001, analysis of variance) and correlated with duration of mechanical ventilation and oxygen treatment. Uu-positive infants had an increased incidence of BPD (88% in infants with Uu vs 42% in infants without Uu; P=0.020) and had TA concentrations of IL-8 and MCP-1 that were significantly increased compared with those of Uu-negative infants.
CONCLUSIONS: Increased TA concentrations of IL-8 and MCP-1 during the first 2 weeks of life are associated with the development of BPD. Recovery of Uu from TAs is associated with a more robust inflammatory reaction and an increased risk of BPD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11478413     DOI: 10.2310/6650.2001.33902

Source DB:  PubMed          Journal:  J Investig Med        ISSN: 1081-5589            Impact factor:   2.895


  21 in total

1.  NF-kappaB in tracheal lavage fluid from intubated premature infants: association with inflammation, oxygen, and outcome.

Authors:  A Bourbia; M A Cruz; H J Rozycki
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-07-27       Impact factor: 5.747

Review 2.  Targeting inflammation to prevent bronchopulmonary dysplasia: can new insights be translated into therapies?

Authors:  Clyde J Wright; Haresh Kirpalani
Journal:  Pediatrics       Date:  2011-06-06       Impact factor: 7.124

3.  Inhaled nitric oxide prevents 3-nitrotyrosine formation in the lungs of neonatal mice exposed to >95% oxygen.

Authors:  Michael R Stenger; Melissa J Rose; Mandar S Joshi; Lynette K Rogers; Louis G Chicoine; John Anthony Bauer; Leif D Nelin
Journal:  Lung       Date:  2010-03-17       Impact factor: 2.584

4.  IκB kinase activity drives fetal lung macrophage maturation along a non-M1/M2 paradigm.

Authors:  Ashley N Stouch; Rinat Zaynagetdinov; Whitney J Barham; Amanda M Stinnett; James C Slaughter; Fiona E Yull; Hal M Hoffman; Timothy S Blackwell; Lawrence S Prince
Journal:  J Immunol       Date:  2014-06-30       Impact factor: 5.422

5.  Blood protein concentrations in the first two postnatal weeks that predict bronchopulmonary dysplasia among infants born before the 28th week of gestation.

Authors:  Carl Bose; Matthew Laughon; Elizabeth N Allred; Linda J Van Marter; T Michael O'Shea; Richard A Ehrenkranz; Raina Fichorova; Alan Leviton
Journal:  Pediatr Res       Date:  2011-04       Impact factor: 3.756

6.  Characterization of a murine model of Ureaplasma urealyticum pneumonia.

Authors:  Rose M Viscardi; Jennifer Kaplan; Judith C Lovchik; Ju Ren He; Lisa Hester; Srinivas Rao; Jeffrey D Hasday
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

7.  Surfactant protein-A limits Ureaplasma-mediated lung inflammation in a murine pneumonia model.

Authors:  Mobolaji E Famuyide; Jeffrey D Hasday; Heather C Carter; Kirsty L Chesko; Ju-Ren He; Rose M Viscardi
Journal:  Pediatr Res       Date:  2009-08       Impact factor: 3.756

8.  Circulating beta chemokine and MMP 9 as markers of oxidative injury in extremely low birth weight infants.

Authors:  Girija Natarajan; Seetha Shankaran; Scott A McDonald; Abhik DAS; Barbara J Stoll; Rosemary D Higgins; Poul Thorsen; Kristin Skogstrand; David M Hougaard; Waldemar A Carlo
Journal:  Pediatr Res       Date:  2010-01       Impact factor: 3.756

9.  Maternal IL-1beta production prevents lung injury in a mouse model of bronchopulmonary dysplasia.

Authors:  Erica Bäckström; Urpo Lappalainen; Kristina Bry
Journal:  Am J Respir Cell Mol Biol       Date:  2009-05-01       Impact factor: 6.914

Review 10.  Role of Ureaplasma species in neonatal chronic lung disease: epidemiologic and experimental evidence.

Authors:  Rose Marie Viscardi; Jeffrey D Hasday
Journal:  Pediatr Res       Date:  2009-05       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.